Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198548 | SCV000250728 | uncertain significance | not provided | 2024-09-04 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000477467 | SCV000549186 | likely benign | Arterial tortuosity syndrome | 2024-11-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315621 | SCV000739645 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-09-08 | criteria provided, single submitter | clinical testing | The p.T472I variant (also known as c.1415C>T), located in coding exon 4 of the SLC2A10 gene, results from a C to T substitution at nucleotide position 1415. The threonine at codon 472 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |